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Background/Aims:  The ability to visualize the small 
bowel mucosa by capsule endoscopy is limited. 
Moreover, studies involving small-bowel preparation 
with purgative drugs have failed to establish which 
preparations produce better images and higher diag-
nostic yields. The aim of this study was to evaluate 
the efficacies and diagnostic yields of different bowel 
preparations.  Methods:  A cohort of 134 patients with 
suspected small bowel disease was randomly as-
signed to 3 groups. Patients in group A (n=44) fasted 
for 12 h before being administered an M2A capsule 
(Given Imaging, Yoqneam, Israel). Patients in group B 
(n=45) were asked to drink two doses of 45 mL of 
sodium phosphate (NaP) with water during the after-
noon and evening on the day before the procedure 
and to drink at least 2 L of water thereafter. Patients 
in group C (n=45) drank 2 L of a polyethylene glycol 
(PEG) lavage solution the evening before the pro-
cedure.  Results:  Overall cleansing of the small bowel 
was adequate in 43% of patients in group A, 77% of 
those in group B, and 56% of those in group C 
(group A vs group B, p=0.001). Diagnoses for ob-
scure gastrointestinal bleeding were established in 9 
patients (39%) in group A, 16 patients (69%) in group 
B, and 14 patients (50%) in group C. No significant 
difference in diagnostic yield was observed between 
groups.  Conclusions:  Bowel preparation with NaP for 
capsule endoscopy improved small-bowel mucosal vis-
ualization when compared to 12-h overnight fasting. 
(Gut and Liver 2009;3:180-185)
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INTRODUCTION
  Capsule endoscopy is a highly effective method for eval-
uating the entire small bowel during its normal peristalsis 
without inconvenience of patients. The diagnostic algo-
rithm for small bowel disease has thus been adapted to 
exploit the excellent diagnostic yield of capsule endoscopy 
compared to that of conventional methods.
1-4
  Despite its diagnostic accuracy, the yield of capsule en-
doscopy can be limited by intestinal contents, food, and 
air bubbles. To obtain better mucosal images via capsule 
endoscopy, some clinicians have prepared the small bowel 
using purgative agents, such as, simethicone, polyethylene 
glycol (PEG), and sodium phosphate (NaP).
5-9 These stud-
ies have generally shown that preparation before capsule 
endoscopy increases the quality of images and the diag-
nostic yield. However, a comparative analysis to establish 
the most effective preparation for capsule endoscopy is 
lacking.
  The aim of this prospective, randomized, single-blind, 
multi-center study was to evaluate the quality of visual-
ization and the diagnostic yield produced by three meth-
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MATERIALS AND METHODS
　A total of 135 patients at 9 tertiary academic hospitals 
were enrolled for the evaluation of suspected small bowel 
disease, including obscure gastrointestinal bleeding, Crohn’s 
disease, chronic abdominal pain and diarrhea, and familial 
polyposis syndrome. All evaluations took place between 
October 2004 and September 2007. We excluded preg-
nant women, patients with suspicious gastrointestinal ob-
struction, patients with any implanted electromedical de-
vice (e.g., cardiac pacemaker or defibrillator), and patients 
less than 18 years old. When capsule endoscopy was 
s c h e d u l e d ,  t h e  p a t i e n t s  w e r e  a s s i g n e d  t o  G r o u p  A ,  B ,  o r 
C by using randomization lists. Group A fasted overnight 
before swallowing the mouth-to-anus (M2A) capsule 
(Given Imaging, Yoqneam, Israel) in the morning, with-
out any supplementary bowel preparation. Group B 
self-administered two bottles of oral NaP, 2 bottles (45 
mL each; Solin
Ⓡ, Korea Pharma Co., Ltd., Seoul, Korea) 
with water, drinking one bottle at 3:00 p.m. and the sec-
ond at 7:00 p.m. the day before the procedure; Group B 
patients were also asked to drink at least 2 L of clear liq-
uid before midnight on the day before the procedure. 
Group C ingested 2 L of a PEG/electrolyte lavage solution 
(Colyte
Ⓡ, Taejoon Pharm Co., Ltd., Seoul, Korea) 16 h 
before the procedure. All patients were requested to in-
gest a liquid diet after a regular breakfast the day before 
the procedure and were allowed to drink clear liquid for 
2 h and have a liquid diet for 4 h after swallowing the 
capsule. At least two expert endoscopists, unaware of the 
type of bowel preparation, evaluated the capsule endos-
copy findings. The gastric emptying time (GET) and the 
small intestinal transit time (SITT) were automatically 
calculated. The GET was defined as the time from the 
first gastric image to the first duodenal image and the 
SITT was defined as the time from the first duodenal im-
age to the first cecal image. 
  The primary study outcome was to evaluate the effects 
of bowel preparation on the quality of images obtained by 
capsule endoscopy. Although few previous studies on 
bowel preparation for capsule endoscopy are available, in-
cluding several studies with a small sample size reported 
in abstract form, we used these reports to calculate the 
necessary sample size for our study. The secondary study 
outcome was to evaluate the effect of preparation on di-
agnostic yield. We used the standard defined by Viazis et 
al.
6 to evaluate the effects of bowel preparation. Obstacles 
such as intestinal contents, intraluminal gas, bile, and 
food were evaluated. The intestinal mucosa was defined 
as clean if, at any time, less than 25% of the mucosal 
surface was covered by intestinal contents, concentrated 
bile, intraluminal gas, and food. By using a timer, inves-
tigators recorded the exact time period during which the 
small intestinal mucosa was not clean. The percentage of 
the SITT during which the small intestinal mucosa was 
not clean was then calculated as an objective score. Small 
bowel cleansing was considered “adequate” if the ob-
jective score was less than 10% and “inadequate” if the 
score was 10% or greater. All investigators independently 
evaluated all of the digital image streams and the ob-
jective score reported for each patient was the mean of 
the values provided by these investigators.
  A subset of patients then underwent further evaluation 
(double balloon enteroscopy, Meckel’s scan, Tc
99 red cell 
scan, small bowel series, or computerized tomography) to 
confirm findings of capsule endoscopy. Final diagnoses 
were established through further evaluation or capsule 
endoscopy alone with a definite positive finding. In the 
diagnosis of Crohn’s disease, capsule endoscopy results 
were defined as positive if four or more obvious clear ul-
cers, erosions, or regions with clear exudates and mucosal 
hyperemia and edema were identified. The patient’s his-
tory and clinical course of the disease were considered 
before a diagnosis of Crohn’s disease was made. The test 
subjects completed a questionnaire and evaluated the dif-
ficulty and side effects of the preparatory method.
1. Ethical considerations 
 All of the patients provided written consent to undergo 
capsule endoscopy. This study was approved by the 
Institutional Review Board of Medical Ethics and the 
Human Clinical Trial Committee at each hospital.
2. Statistical analysis
  Quantitative data were summarized as the mean and 
standard deviation (SD). Continuous measures were ana-
lyzed using analysis of variance (ANOVA). Nonparametric 
data were compared by the Kruskal-Wallis test and cate-
gorical measures were compared by using the chi-square 
test or Fisher’s exact test. p-values＜0.05 were considered 
statistically significant, and all statistical analyses were 
performed using SPSS 11.5 (SPSS Inc., Chicago, IL, USA). 
When each variable was compared to the other two, cate-
gorical data were analyzed using the chi-square test with 
Bonferroni correction. The significance level was therefore 
adjusted to p＜0.017.
RESULTS
1. Patient characteristics
  A total of 135 patients underwent capsule endoscopy. 
Among the patients in Group A, one patient was ex-182   Gut and Liver, Vol. 3, No. 3, September 2009
Table 1. Patient Characteristics and Indications for Capsule Endoscopy
Group A overnight
fast (n=44)
Group B NaP
(n=45)
Group C PEG
(n=45)
p-value
  Age (yr) 53.1±15.7 50.0±17.1 45.7±16.8   0.07
  Sex (M/F) 27/17 25/20 33/12   0.20
  I n d i c a t i o n    0 . 8 5 9
    Overt GI bleeding 16 16 19
    O c c u l t  G I  b l e e d i n g  7  7  9
    Chronic abdominal pain 10 10 11
    C h r o n i c  d i a r r h e a  4  4  3
    Suspicious Crohn’s disease  2  1  2
    O t h e r s  5  7  1
NaP, sodium phosphate; PEG, polyethylene glycol; GI, gastrointestinal.
Table 2. Transit Times and Quality of Image
Group A overnight
fast (n=44)
Group B NaP
(n=45)
Group C PEG
(n=45)
p-value
  GET (min) 34.9±32.3 47.2±61.2  25.2±32.2 0.136
  SITT (min) 321.8±116.3 313.5±100.9 337.6±99.3 0.667
  ICV passing (No.) 33 33 32 0.924
  “Adequate” cleansing number of 19 (43%) 33* (77%) 25 (56%)   0.002
†
    the small bowel (% of patients)
NaP, sodium phosphate; PEG, polyethylene glycol; GET, gastric emptying time; SITT, small intestinal transit time; ICV, ileocecal 
valve.
*p=0.001, compared with NPO group, p=0.123 compared with PEG group; 
†
p=0.002, comparison among three groups.
cluded because the capsule did not traverse the 
duodenum. Consequently, 134 patients (85 men and 49 
women) were analyzed.  Groups A, B, and C contained 
44, 45, and 45 subjects, respectively. Mean ages were as 
follows: 53.1 years for Group A, 50.0 years for Group B, 
and 45.7 years for Group C. The most common indication 
in all three groups was obscure overt gastrointestinal (GI) 
bleeding in each group. No significant difference was ob-
served among the three groups in terms of age, sex, or 
indication (Table 1).
2. Transit time and quality of images
  The mean GET was 34.9 min for Group A, 47.2 min for 
Group B, and 25.2 min for Group C. The mean SITT was 
321.8 min for Group A, 313.5 min for Group B, and 
337.6 min for Group C. The capsule reached the cecum 
in 33 patients in Group A (75%), 33 patients in Group B 
(73%), and 32 patients in Group C (71%). No significant 
difference was difference was observed among groups re-
garding GET, SITT, or the percentage of patients in 
whom the capsule reached the cecum. All capsules were 
retrieved except one which was blocked at ileum because 
of a stricture with Crohn’s disease. After 4 weeks later, 
retention capsule was spontaneously eliminated. The 
number of patients with “adequate” cleansing of the 
small intestine was 19 in Group A (43%), 33 in Group B 
(77%), and 25 in Group C (56%). The mean percentage 
of patients with “adequate” cleansing was significantly 
different among the three groups (p=0.002). In compar-
ison with the other subgroups, Group B had significantly 
better image quality than Group A (p=0.001; Table 2). 
No significant difference in image quality was observed 
Group B and C, or between Group A and C.
3. Diagnostic yield of capsule endoscopy
    In patients with obscure gastrointestinal bleeding, a 
definite diagnosis was established for nine patients (39%) 
in Group A, 16 patients (69%) in Group B, and 14 pa-
tients (50%) in Group C (p=0.111). In patients with 
non-obscure gastrointestinal bleeding, a definite diagnosis 
was established for 14% of patients in Group A, 27% in 
Group C, and 33% in Group C (p=0.739; Tables 3 and 
4). No significant difference was observed among groups 
in terms of diagnostic yield. 
4. Tolerability of preparation
  All patients completed the preparations without sig-
nificant adverse effects. Thirty-one patients (69%) in 
Group B and 24 patients (56%) in Group C had no com-
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Table 3. Capsule Endoscopy Findings in Obscure GI Bleeding
Group A overnight
fast (n=23)
Group B NaP
(n=23)
Group C PEG
(n=28)
p-value
  P o s i t i v e 0.111
    U l c e r 4 7 5
    E r o s i o n s 0 2 2
    A n g i o d y s p l a s i a s 2 4 4
    Crohn’s disease 2 2 1
    Diverticulum 0 1 1
    T u m o r / P o l y p 1 0 1
  S u s p i c i o u s
    E r o s i o n 4 2 5
    S u b m u c o s a l  t u m o r 2 1 0
    O n l y  b l o o d 1 0 0
    V e n o d i l a t i o n 1 0 0
  N e g a t i v e 6 4 9
GI, gastrointestinal; NaP, sodium phosphate; PEG, polyethylene glycol.
Table 4. Capsule Endoscopy Findings in Non-GI Bleeding
Group A overnight
fast (n=21)
Group B NaP
(n=22)
Group C PEG
(n=17)
p-value
  P o s i t i v e 0.739
    Crohn’s disease  1  3 3
    U l c e r  1  2 1
    S u b m u c o s a l  t u m o r  0  0 1
    P o l y p o s i s  0  1 0
  S u s p i c i o u s
    Nonbleeding angiodysplasia  2  2 1
    E r o s i o n s  4  3 2
    Extrinsic compression  0  1 0
    P o l y p  1  0 0
  Negative 14 10 9
GI, gastrointestinal; NaP, sodium phosphate; PEG, polyethylene glycol.
Table 5. Patient Questionnaire on Preparation Tolerability by 
Group
Group B
NaP
Group C
PEG
p-value
How easy to complete? NS
  Easy 31 25
  Slightly difficult  6 10
  Moderately difficult  4  6
  Extremely difficult  4  4
  U n a b l e  t o  f i n i s h  0  0
Side effect NS
  Nausea 12 20
  V o m i t i n g  6  5
  A b d o m i n a l  p a i n  2  7
  B l o a t i n g  2  4
NaP, sodium phosphate; PEG, polyethylene glycol; NS, not 
significant.
adverse effect was nausea in Groups B and C. No patient 
complained of a complication associated with capsule 
ingestion. All capsules were retrieved, but the passage of 
one capsule was delayed due to blockage at the ileum be-
cause of a stricture associated with Crohn’s disease 
(Table 5).
DISCUSSION
  Many studies have reported that capsule endoscopy is 
an effective tool for the evaluation of small bowel disease, 
with investigators using various methods to prepare pa-
tients to improve mucosal visualization.
1-4 Generally, al-
though these methods associated with preparation of cap-
sule endoscopy increase the quality of image, bowel prep-
aration for capsule endoscopy has not been standardized.
5-9 
The present study is the first prospective randomized 
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and PEG, which is the most common purgative agent for 
capsule endoscopy. Our study showed that bowel prepara-
tion with NaP for capsule endoscopy improved the small 
bowel mucosa visualization, as compared to those of 12-h 
overnight fast. 
  Preparation methods involving PEG and NaP were de-
rived from methods used with colonoscopy. However, be-
cause capsule endoscopy visualizes the small bowel rather 
than the colon, colonic purgation methods intended as 
preparation for colonoscopy may not be suitable. In stud-
ies with PEG, various doses (ranging from 500 mL to 4 
L) were adapted for use in capsule endoscopy, with con-
tradictory results.
6-8,10-12 Some studies showed that PEG 
preparation before capsule endoscopy improved visual-
ization of the small intestine, whereas other studies 
showed no significant difference between PEG treatment 
and control groups. In the present study, preparation with 
PEG affected neither the quality of the capsule endoscopy 
image nor its diagnostic yield compared to 12-h overnight 
fasting. To the best of our knowledge, the present study 
is the first to compare NaP and PEG as preparation meth-
ods for capsule endoscopy. We observed no difference in 
image quality between patients prepared with NaP plus 2 
L of clear liquid vs those prepared with 2 L of PEG. This 
is in contrast to previous studies on preparation for colo-
noscopy demonstrating that superior cleansing is achieved 
w h e n  P E G  i s  a d m i n i s t e r e d  w h o l l y  o r  i n  p a r t  o n  t h e  d a y  
of the procedure.
13,14  The fact that PEG treatment con-
ferred no additional benefit in the present study likely re-
flects differences in administration time and the amount 
of PEG used. In addition, sample size may also be an im-
portant factor affecting both the primary and secondary 
outcomes. Prior to the study, we calculated the required 
sample sized based on the findings of previous studies. 
However, because these studies were few in number and 
also relied upon small sample sizes, our sample size have 
been insufficient to detect differences between the prepa-
rations studied. 
  Unfortunately, as there is no gold standard for capsule 
endoscopy recordings, capsule endoscopy is not always di-
agnostic, and a significant number of false positive and 
false negative findings occur. Careful consideration must 
be given to the interpretation of capsule endoscopy find-
ings. Pennazio et al.
15 divided the findings of capsule en-
doscopy into three groups, including positive, suspicious, 
and negative findings. In the present study, we were not 
able to confirm all positive findings obtained via capsule 
endoscopy by means of surgery, enteroscopy, or other 
studies. Further evaluation for obscure GI bleeding was 
only done in 4 patients from Group A, 10 from Group B, 
and 7 from Group C respectively. Final diagnosis based 
on further evaluation agreed with the findings of capsule 
endoscopy, and there was no change in the initial diag-
nosis during follow-up of patients who were diagnosed by 
capsule endoscopy findings alone. For suspicious findings, 
further evaluation was done 4 in Group A, 1 in Group B, 
and 1 Group C  which showed the false positive results 
of capsule endoscopy and the initial diagnosis was 
changed in these patients. Therefore, for patients who 
showed suspicious findings, we recommend performing 
additional studies. No significant difference was observed 
among groups for the diagnostic yield in non-obscure GI 
bleeding. We interpreted these results based on the fact 
that the most common indications were chronic abdomi-
nal pain and diarrhea, which were possibly due to func-
tional disease, such as irritable disease, as opposed to or-
ganic disease. It is unclear whether the method of prepa-
ration influences GET, SITT, or cecal completion rate. 
Although some investigators have reported that bowel 
preparations such as PEG increased passage beyond the 
ileo-cecal valve (ICV),
8,16 w e  o b s e r v e d  n o  s i g n i f i c a n t  d i f -
ference in passage beyond the ICV according to prepara-
tion method. 
  The present study has some limitations. Our study was 
multi-center study with multiple investigators. Images of 
all capsule endoscopies were not reviewed by all inves-
tigators; at least two investigators from each hospital re-
viewed the images from their cases alone. Therefore, our 
study results may reflect inter-observer differences. The 
k a p p a  v a l u e  m a y  h a v e  d e c r e a s e d  in  r e s p o n s e  t o  t h e  r e l a-
tively small sizes at each hospital and the fact that not all 
investigators reviewed the study design. However, to re-
duce such inter-observer differences, the authors called a 
meeting before the start of the study to thoroughly ob-
jectify evaluation of images.
  Many aspects of preparation for capsule endoscopy is 
not established. Previous studies on preparation for cap-
sule endoscopy have been extremely heterogeneous in 
terms of type of preparation, dose, and time of admini-
stration. In addition, the evaluation system for bowel 
cleanliness tends to differ for each study, because meth-
ods for assessing the quality of images are chosen 
arbitrarily. Future comparative studies to determine the 
optimal preparation method for capsule endoscopy will 
require an objective, standardized method to evaluate 
cleanliness. It is our hope that additional studies on prep-
aration methods for capsule endoscopy, ideally examining 
several preparatory methods and purgative agents 
( in c lu d in g  p ro k in e t ic s )  w ill b e  c o n tin u e d , s o  th a t  w e  c a n 
compare the results with our own. In this study, no sig-
nificant difference wa observed between the NaP and PEG 
groups in terms of visualization of the small bowel. Wi JH, et al: Bowel Preparation for Capsule Endoscopy: A Prospective Randomized Multicenter Study   185
However, preparation with NaP before capsule endoscopy 
improved mucosal visualization compared to 12-h over-
night fasting.
  In conclusion, the results of our prospective study sug-
gest that bowel preparation with NaP improves the qual-
ity of capsule endoscopy images. Nevertheless, no sig-
nificant difference in diagnostic yield was observed among 
groups. Additional, larger scale studies on the effect of 
various bowel preparation methods on the diagnostic 
yield of capsule endoscopy are required. 
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